Myriad Genetics reported $1.61B in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Accelerate Diagnostics AXDX:US USD 152M 73M
Agilent A:US USD 35.98B 506M
Becton, Dickinson and BDX:US USD 63.55B 6.76B
Bio Rad Laboratories BIO:US USD 12.4B 2.31B
Biocept BIOC:US USD 16M 0
Bruker BRKR:US USD 7.86B 1.51B
Danaher DHR:US USD 193.22B 5.32B
Exact Sciences EXAS:US USD 5.75B 1.18B
Fluidigm FLDM:US USD 87M 37M
Hologic HOLX:US USD 16.11B 1.17B
Illumina ILMN:US USD 29.97B 1.01B
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Mettler Toledo International MTD:US USD 24.17B 1.68B
Myriad Genetics MYGN:US USD 1.54B 74M
Nanostring Technologies NSTG:US USD 594M 4M
Orasure Technologies OSUR:US USD 275M 79M
Pacific Biosciences Of California PACB:US USD 1.31B 313M
Perkinelmer PKI:US USD 15.19B 2.75B
Quest Diagnostics DGX:US USD 13.99B 1.57B
Quidel QDEL:US USD 4.79B 1.72B
Repligen RGEN:US USD 10.38B 1.38B
Thermo Fisher Scientific TMO:US USD 198.71B 13.96B
Veracyte VCYT:US USD 1.19B 234M
Waters WAT:US USD 16.14B 3.8B